(IBHI) iShares iBonds 2029 Term - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E3797

HighYield Corporate Bonds, FixedRate Securities, BBB Rated Bonds

Description: IBHI iShares iBonds 2029 Term

The iShares iBonds 2029 Term High Yield and Income ETF (IBHI) is designed to track an index of high yield and BBB-rated corporate bonds maturing between 2029. This ETF provides investors with exposure to a diversified portfolio of high yield bonds with a specific maturity date, allowing for more precise liability matching and investment planning.

From a trading perspective, its essential to monitor the ETFs liquidity, given its relatively modest AUM of $179.30M. This may impact trading costs, particularly for larger investors. Key performance indicators (KPIs) to track include the ETFs yield, duration, and credit quality, as these will influence its sensitivity to interest rate changes and credit risk.

The ETFs non-diversified nature and potential investment in non-U.S. issuers may introduce additional risks, such as concentration risk and foreign exchange risk. Investors should be aware of these risks and monitor the ETFs holdings and credit profile to ensure alignment with their investment objectives. Other relevant KPIs include the ETFs expense ratio, tracking error, and average credit quality, which can impact its overall performance and risk profile.

To evaluate the ETFs potential, investors can analyze its historical performance, including its returns relative to its benchmark and peers. Additionally, examining the ETFs sector allocation, industry exposure, and issuer concentration can provide insights into its potential vulnerabilities and opportunities. By closely monitoring these KPIs, investors can make more informed decisions about their investment in IBHI.

IBHI ETF Overview

Market Cap in USD 232m
Category Target Maturity
TER 0.35%
IPO / Inception 2022-03-08

IBHI ETF Ratings

Growth Rating 75.5%
Fundamental -
Dividend Rating 79.7%
Return 12m vs S&P 500 -9.57%
Analyst Rating -

IBHI Dividends

Dividend Yield 12m 6.99%
Yield on Cost 5y 8.20%
Annual Growth 5y 11.07%
Payout Consistency 100.0%
Payout Ratio %

IBHI Growth Ratios

Growth Correlation 3m 97%
Growth Correlation 12m 81.4%
Growth Correlation 5y 91.4%
CAGR 5y 10.18%
CAGR/Max DD 3y 1.78
CAGR/Mean DD 3y 17.45
Sharpe Ratio 12m 1.06
Alpha 0.01
Beta 0.927
Volatility 3.47%
Current Volume 130.8k
Average Volume 20d 67.2k
Stop Loss 23 (-3.3%)
Signal 0.12

What is the price of IBHI shares?

As of September 19, 2025, the stock is trading at USD 23.79 with a total of 130,848 shares traded.
Over the past week, the price has changed by +0.21%, over one month by +1.32%, over three months by +3.78% and over the past year by +7.19%.

Is iShares iBonds 2029 Term a good stock to buy?

Yes. Based on ValueRay's Analyses, iShares iBonds 2029 Term (BATS:IBHI) is currently (September 2025) a good stock to buy. It has a ValueRay Growth Rating of 75.47 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBHI is around 24.12 USD . This means that IBHI is currently overvalued and has a potential downside of 1.39%.

Is IBHI a buy, sell or hold?

iShares iBonds 2029 Term has no consensus analysts rating.

What are the forecasts/targets for the IBHI price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 27.1 14%

Last update: 2025-09-09 04:39

IBHI Fundamental Data Overview

Market Cap USD = 231.8m (231.8m USD * 1.0 USD.USD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.8
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 231.8m USD (231.8m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 231.8m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 231.8m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(231.8m)/V(0.0) * Re(9.43%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 9.43% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for IBHI ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle